Ledger.Open graph →
SEC Form D · filed February 25, 2019

Neurogene Inc

Offering
$37.5M
Sold
$37.5M
Exemption
Rule 506(b)
Industry
Other
Location
NEW YORK, NY
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (6)

Stephen Biggar · New York, NYDirectorCory Freedland · New York, NYDirectorRachel Mcminn · New York, NYExec · DirectorStephen Biggar · New York, NYDirectorCory Freedland · New York, NYDirectorRachel Mcminn · New York, NYExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗